A University of Bath-led project, GlucoBrain, received £500,000 to develop an organ-on-chip device that replicates interactions between the brain, gut, and pancreas, aiming to uncover mechanisms linking diabetes with cognitive decline. This technology could lead to new treatments for millions affected by these conditions and accelerate drug discovery through more accurate human cell models.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





